• A distinctive acral erythema developed in four patients with myelogenous leukemia, subsequent to blood transfusions and intensive chemotherapy with cytarabine. The clinical and histopathologic features of the eruption were suggestive of a drug-induced toxic eruption. To our knowledge, only one previous similar case has been reported in the literature. For patients in whom this self-limited condition develops, reassurance should serve as the mainstay of therapy.
(Arch Dermatol 1985;121:102-104)
Levine LE, Medenica MM, Lorincz AL, Soltani K, Raab B, Ma A. Distinctive Acral Erythema Occurring During Therapy for Severe Myelogenous Leukemia. Arch Dermatol. 1985;121(1):102–104. doi:10.1001/archderm.1985.01660010106031
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: